{"cik":1770069,"taxonomy":"us-gaap","tag":"EarningsPerShareBasic","label":"Earnings Per Share, Basic","description":"The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.","entityName":"MapLight Therapeutics, Inc.","units":{"USD/shares":[{"start":"2024-01-01","end":"2024-09-30","val":-77.37,"accn":"0001193125-25-307453","fy":2025,"fp":"Q3","form":"10-Q","filed":"2025-12-04"},{"start":"2024-07-01","end":"2024-09-30","val":-25.08,"accn":"0001193125-25-307453","fy":2025,"fp":"Q3","form":"10-Q","filed":"2025-12-04","frame":"CY2024Q3"},{"start":"2024-01-01","end":"2024-12-31","val":-105.38,"accn":"0001193125-26-125072","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-26","frame":"CY2024"},{"start":"2025-01-01","end":"2025-03-31","val":-29.33,"accn":"0001193125-26-224129","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-14","frame":"CY2025Q1"},{"start":"2025-01-01","end":"2025-09-30","val":-105.7,"accn":"0001193125-25-307453","fy":2025,"fp":"Q3","form":"10-Q","filed":"2025-12-04"},{"start":"2025-07-01","end":"2025-09-30","val":-37.18,"accn":"0001193125-25-307453","fy":2025,"fp":"Q3","form":"10-Q","filed":"2025-12-04","frame":"CY2025Q3"},{"start":"2025-01-01","end":"2025-12-31","val":-18.56,"accn":"0001193125-26-125072","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-26","frame":"CY2025"},{"start":"2026-01-01","end":"2026-03-31","val":-1.34,"accn":"0001193125-26-224129","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-14","frame":"CY2026Q1"}]}}